Cell adhesion promotes cellular proliferation through the regulation of gene expression, including the immediate early genes. However, the precise role of cell adhesion in the regulation of the c-Myc proto-oncogene is not clear, and the adhesion-dependent signaling pathway(s) regulating the expression of c-Myc has yet to be de®ned. We now show that integrin signaling directly regulates the expression of c-Myc in the mammary epithelial cell line 184A1N4 (A1N4). 
Introduction
Cell adhesion to the extracellular matrix cooperates with hormones and growth factors to regulate cell proliferation. Members of the b1 and b4 families of integrins have been implicated for the control of cell proliferation, both in vitro and in vivo (Mortarini et al., 1995; Udagawa et al., 1995; Murgia et al., 1998) . Integrin engagement and subsequent integrin aggregation lead to the formation of focal adhesions. These events not only enhance the activation of growth factor receptors, but also induce multiple interconnecting signaling pathways (Miyamoto et al., 1996; Moro et al., 1998; Giancotti and Ruoslahti, 1999) . A number of signaling molecules are recruited and activated at the sites of focal adhesions, including FAK, PKC, the cSrc family of kinases, and the MAP kinases. PKC has been shown to modulate the activity of c-Src and of the MAP kinase pathway (Vuori and Ruoslahti, 1993; Schlaepfer et al., 1998; Miranti et al., 1999; Howe and Juliano, 1998) . In addition, the activation of MEK is greatly decreased in c-Src knockout cells, indicating that the MAP kinase pathway may mediate some of the eects of c-Src . These signaling pathways have been implicated in the regulation of cell cycle progression. Overexpression of Ras or Src results in anchorage-independent cell growth. However, the molecular mechanisms by which adhesion-dependent signaling pathways contribute to the regulation of the cell cycle still need to be further explored.
One of the mechanisms by which integrin-mediated adhesion participates in the control of cell cycle progression is through the regulation of the immediate early genes. Cell adhesion is strictly required for the expression of c-Jun and c-Fos (Dike and Farmer, 1998; Dike and Ingber, 1996) . In contrast, some discrepancies are present in the literature on the role of cell adhesion in the regulation of c-Myc. While cellsubstrate adhesion modulates the levels of c-Myc mRNA in bovine capillary endothelial cells, no immediate decrease in c-Myc message is observed in mouse BALB/c3T3 and primary ®broblasts when deprived of adhesion.
While the adhesion-induced signaling pathways leading to the expression and activation of the Jun/ Fos transcription factor have been extensively studied, the integrin-induced signaling pathway(s) regulating the expression of c-Myc/Max have not yet been delineated. Growth factors induce the expression of c-Myc, notably via the`c-Src pathway' (Barone and Courtneidge, 1995) . In addition, the MAP kinase pathway has been shown to mediate regulation of the expression of c-Myc in response to v-Abl and CSF-1 (Weber et al., 1997; Cheng et al., 1999) . Cell adhesion signaling may have some similarities to growth factor signaling. Therefore, some components(s) in an adhesion signaling pathway(s) may function to potentiate or synergize with growth factor signaling to allow cells to overcome a threshold level required to induce the expression of cMyc. Alternatively, cell adhesion may provide addi-tional, independent signals to supplement the growth factor eect on expression of c-Myc.
In this study we have examined the eect of interaction of cell-ECM components on the expression of c-Myc in human mammary epithelial cells. We have shown that cellular adhesion to speci®c extracellular matrix components modulates the expression of c-Myc. In addition, we have demonstrated the presence of a b1 integrin-signaling pathway that promotes expression of the c-Myc protein, independent of growth factors. This integrin-induced regulation of c-Myc is mediated by the PKC, c-Src-family of kinases and Erk 1/2 MAP kinase.
Results

Adhesion of epithelial cells to ECM components modulates their level of c-Myc
To investigate the role of cell-substrate adhesion in the regulation of the c-Myc early gene in human mammary epithelial cells, we used a non-transformed human mammary epithelial cell line, A1N4. When maintained in low serum in the absence of epidermal growth factor (EGF), the A1N4 cells arrest in a quiescent G0/G1 state, which correlates with a low level of c-Myc expression. Stimulation of these cells in monolayer with EGF results in a rapid induction of the c-Myc protein (Stampfer et al., 1993) (Figure 1 ). However, in contrast to adherent cells, non-adherent A1N4 cells cannot maintain elevated levels of c-Myc in response to the EGF stimuli (Figure 1 ). In order to evaluate further the role of cell adhesion in the regulation of c-Myc, we tested the ability of ECM components to alter the levels of c-Myc in cells exposed to EGF. Non-adherent cells that expressed low levels of c-Myc, were allowed to re-attach to untreated plastic tissue culture dishes or to ®bronectin-coated petri dishes in the presence of EGF. Attachment of the cells to ®bronectin speci®cally and rapidly enhanced the induction of c-Myc, as compared to cells adhering to plastic (Figure 1 ).
Cellular adhesion to ECM components induces the expression of c-Myc in the absence of growth factors
Since adhesion of A1N4 cells to ECM components enhances the EGF-induced expression of c-Myc, we wished to test the hypothesis that cell adhesion, independent of growth factor receptor pathways, participates in the regulation of the expression of cMyc. Therefore, we asked whether adhesion of quiescent A1N4 cells to a ECM-coated plates can induce the expression of c-Myc in the absence of exogenous EGF (Figure 2 ). Bacterial petri dishes were coated with 1 mg/cm 2 of ECM, and then blocked with BSA to prevent the non-speci®c adhesion of cells. Quiescent A1N4 cells were detached with EDTA and replated onto either ®bronectin, collagen type I, or collagen type IV-coated plates in synchronization medium containing no EGF. Western blots indicated that the levels of c-Myc were transiently increased following adhesion and spreading of cells on both ®bronectin, collagen type I, and collagen type IV (Figure 2a ).
More precise analysis of the dynamics of the induction of c-Myc by ®bronectin showed that the levels of c-Myc mRNA start to increase at 30 min following adhesion to ®bronectin, peaking by 1 h (Figure 2b) . Treatment of cells with cycloheximide did not alter the induction of c-Myc MRNA, indicating that ®bronectin-dependent transcriptional induction of c-Myc is independent of protein synthesis. The levels of c-Myc protein paralleled its mRNA, peaking within 1 h of cell adhesion to ®bronectin and remaining elevated for up to 3 h (Figure 2c ). No induction of c-Myc was detected when adherent quiescent cells were refed with synchronization medium lacking EGF, or when the cells detached and maintained in suspension for 1 h (data not shown). Furthermore, cell adhesion on ®bronectin induced the expression of c-Myc protein in a ®bronectin concentration-dependent manner (Figure 2d ). The expression of c-Myc reached a maximum when the cells were plated on a ®bronectin concentration of 1 mg/cm 2 . Further increases in ®bronectin concentration did not result in additional increases in levels of c-Myc (data not shown).
Cytoskeletal rearrangement and integrin aggregation are required for the induction of c-Myc
To examine whether the integrity of the cytoskeleton is required for adhesion-dependent induction of c-Myc, cells were treated with the inhibitor of actin ®lament polymerization, cytochalasin D, before plating them Figure 1 Adhesion to ®bronectin enhances EGF-dependent induction of c-Myc. Quiescent A1N4 cells were trypsinized, resuspended in medium containing 10 ng/ml of EGF, and either replated onto tissue culture dishes (A), or held in suspension for 4 hrs (S). The cells maintained in suspension were transferred to either plastic tissue culture dishes (TC), or dishes coated with ®bronectin (FN), in the presence of EGF. Cells were allowed to adhere for the indicated times. Non-adherent cells were washed away with PBS, and the attached cells were lysed, and analysed by Western blotting for their levels of c-Myc onto ®bronectin. Cytochalasin D treatment strongly decreased, but did not totally block, the ®bronectin-dependent induction of c-Myc (Figure 3a) . Treatment of cells with the DMSO solvent, as a control, did not alter the increase of c-Myc induced by cell adhesion to ®bronectin.
We next asked whether interaction of cells with ®bronectin could induce c-Myc expression in suspension cultures. Incubation of non-adherent cells with soluble ®bronectin, at concentrations of up to 10 mg/ ml, failed to induce the expression of Myc (Figure 3b , left panel). In the absence of a solid substrate, binding of integrins to soluble ®bronectin may fail to induce integrin aggregation and the formation of focal adhesion complexes, which are necessary to initiate integrin-mediated signal transduction pathways. A previous report from Plopper and Ingber (1993) has shown that 4.5 mm microbeads coated with ®bronectin can induce the formation of focal adhesion complexes. . Cells were collected, and whole cell lysates were prepared and analysed by Western blot for levels of c-Myc induction observed in cells adhering to ®bronectin-coated plates. One possible explanation is that the number of beads present in suspension may be limiting for maximal induction of the expression of c-Myc. In addition, the cell spreading and the cytoskeletal rearrangement resulting from cell-surface interactions may be needed for optimal signaling. To control for non-speci®c eects of the beads, we incubated A1N4 cells in suspension with magnetic beads coated with BSA. BSA-coated beads did not signi®cantly induce expression of c-Myc (Figure 3b ).
b1 integrins engagement induces the expression of c-Myc
To speci®cally address the role of integrins in the stimulation of the expression of c-Myc following cellular adhesion to ®bronectin, we used integrinspeci®c blocking antibodies. Cellular adhesion to ®bronectin can be mediated by a4b1, a5b1, avb1, and avb3 integrin heterodimers. Flow cytometric analysis indicates that A1N4 cells express a4, a5, a2, b1 integrin subunits, but only very low levels of avb3 on their cell surface, suggesting that avb3 integrin is not implicated in the adhesion dependent-regulation of c-Myc in A1N4 cells (data not shown). To directly test the involvement of b1 integrins in the regulation of c-Myc, we used a function-blocking antibody against the b1 integrin subunit, mAb13 (Akiyama et al., 1989; Yamada et al., 1990) . A1N4 cells were preincubated for 20 min with either b1-integrin blocking antibody or with rat IgG as a control. The cell-antibody mix was then transferred to ®bronectin-coated dishes for 1 h. Treatment of cells with b1 integrin-blocking antibody, but not with rat IgG, diminished by 10-fold the ®bronectin-dependent upregulation of c-Myc ( Figure  4a ). In addition, ®bronectin-dependent induction of cMyc was blocked in an antibody concentrationdependent manner (Figure 4b ). Addition of either anti-human a5 integrin blocking-antibody (clone P1D6), or anti-human a4 integrin blocking-antibody (clone P1H4), either singly or in combination, did not impede ®bronectin-dependent induction of c-Myc (data not shown). Similarly, the blocking antibody against a2b1, a laminin receptor highly expressed on the surface of A1N4 cells, did not block the induction of c-Myc in response to cellular adhesion to ®bronectin (data not shown). This indicates that the inhibition induced by mAb13 was not the result of steric hindrance blocking cell adhesion. Taken together, our results demonstrate that adhesion to ®bronectin can induce the expression of c-Myc independent of the growth factor pathways. Furthermore, ®bronectin-dependent stimulation of c-Myc expression is driven by a b1 integrin pathway.
Role of c-Src in fibronectin-dependent induction of c-Myc
We next wished to investigate the eector molecules involved in the regulation of c-Myc by b1 integrins. A possible candidate is the c-Src phosphotyrosine kinase. The c-Src kinase has been previously implicated in the regulation of c-Myc by growth factor receptors (Barone and Courtneidge, 1995) . In addition, c-Src is recruited at the sites of the focal adhesion, where it phosphorylates on tyrosine residues a number of signal transduction proteins (Clark and Brugge, 1995; . However, no previous studies have addressed the role of c-Src in integrin-mediated control of the expression of c-Myc. In agreement with the role of c-Src in integrin-mediated signal transduction, adhesion and spreading of quiescent A1N4 cells on ®bronectin induce the activity of c-Src kinase within 30 min of cell adhesion and peaking at 1 h following attachment (Figure 5a ). This induction of c-Src activity correlated with an increase in tyrosine phosphorylation of several cellular proteins, including the focal adhesion kinase (FAK) on tyrosine 861, which is a major c-Src phosphorylation site. These tyrosine phosphorylation events could be blocked by the Src kinase family inhibitor PP1 (Pyruzolopyrimidine) (Figure 5b) .
To test the role c-Src in the adhesion-dependent induction of c-Myc, we treated quiescent A1N4 cells with the phosphotyrosine inhibitor, Herbimycin A, and with the c-Src family-speci®c pharmacological inhibitor, PP1. Both inhibitors, but not the DMSO vehicle control, blocked in a dose-dependent fashion the induction of c-Myc, following adhesion to ®bronectin (Figure 5c ). These results suggest that the c-Src family of tyrosine kinases is required in ®bronectin-dependent induction of c-Myc.
Involvement of MEK in adhesion-dependent regulation of c-Myc
The Raf/Mek/MAP Kinase pathway has been implicated in the regulation of proliferation by adhesion (Roovers et al., 1999) . Furthermore, this pathway has been shown to mediate some of the eects of c-Src (Hakak and Martin, 1999; Schlaepfer et al., 1998; Aziz et al., 1999) . To determine if the activity of MEK1 is required for ®bronectin-mediated induction of c-Myc, we examined the eect of the speci®c MAP kinase kinase inhibitor PD98059 (Alessi et al., 1995) . Treatment of quiescent A1N4 cells with this inhibitor prevented the ®bronectin-dependent induction of cMyc in an inhibitor dose-dependent manner ( Figure  6a ). Western blot analysis, using an antibody speci®c for the phosphorylated form of the MEK1 substrates, Erk1 and Erk2, indicated that Erk1/2 is transiently phosphorylated in A1N4 cells, within 30 min of adhesion of ®bronectin. This activation of MEK, following adhesion to ®bronectin, precedes the induction of c-Myc (Figure 6b) . Treatment of cells with 50 mM PD98059 prevents the phosphorylation of Erk1/ 2, demonstrating that the inhibitor eectively blocks ®bronectin-induced activation of MEK1 (Figure 6b ). The membranes were stripped and reprobed with an antibody against total Erk1/2 to verify that the variations observed in Erk 1/2 phosphorylation levels are not due to a modulation in the expression of Erk (Figure 6b ). These results indicate that the increase in MEK1 activity, following cell adhesion onto ®bronec-tin, correlates with expression of c-Myc. Furthermore, inhibition of MEK1 can block adhesion-dependent induction of c-Myc.
Involvement of PKC in the adhesion-dependent induction of c-Myc
Several lines of evidences have implicated PKC in integrin-mediated events. PKC has been proposed to be an upstream modulator of the c-Src and MAPK pathways (Vuori and Ruoslahti, 1993; Miranti et al., 1999; Schlaepfer et al., 1998) . We used two PKC inhibitors, Staurosporine and Calphostin C, to address the role of PKC in the adhesion-dependent regulation of c-Myc. Inhibition of PKC with Calphostin C entirely blocked ®bronectin-induced expression of c- (Figure 7) . In contrast, the PKA inhibitor, H89 did not alter the induction of c-Myc. In addition, 24 h of pretreatment of A1N4 cells with TPA, which decreases the levels of the TPA responsive PKC, blocked the induction of c-Myc in response to adhesion, although it did not aect the ability of A1N4 cells to adhere and spread onto ®bronectin (Figure 7 ).
Discussion
Although cell adhesion-initiated signaling pathways have been extensively studied, many gaps remain to link these signaling cascades to the regulation of cell proliferation. In this study, we have demonstrated the existence in human mammary epithelial cells of an ECM receptor (integrin)-initiated signaling pathway leading to the expression of c-Myc, independent of growth factor receptor signaling. Adhesion of quiescent A1N4 cells to the basement membrane component, collagen type IV, and to the stromal components, ®bronectin and collagen type I, induced the expression of c-Myc. In addition, we deliniated an adhesioninduced signaling pathway regulating the induction of c-Myc.
The b1 integrins have been implicated in the regulation of proliferation of mammary epithelial cells, both in vitro and in vivo. Disruption of b1 integrin function results in a decrease in mammary epithelial cell proliferation both in a transgenic mouse model and in tissue culture (Faraldo et al., 1998; Weaver et al., 1997) . In addition, the cytoplasmic tail splice variant of b1 integrin, integrin b1C, which is normally expressed in non-proliferating, dierentiated epithelial cells, has been described as a growth inhibitor (Fornaro et al., 1998; Manzotti et al., 2000) . We now provide evidence for one of the molecular mechanism by which b1 integrins regulate epithelial cell proliferation. Using a function-blocking antibody, we have demonstrated that b1 integrins mediate the induction of c-Myc in response to cell adhesion to ®bronectin. Furthermore, the enforced expression of b1C integrin results in an increase in the levels of p27, suggesting that it is an upstream regulator of p27 (Fornaro et al., 1999) . Interestingly, c-Myc induces the degradation of p27. Therefore, b1C integrin may function as a naturally occurring, dominant negative form of b1 integrins. b1C may inhibit integrin-mediated induction of c-Myc, resulting in the stabilization of p27. Our results indicate that adhesion-dependent regulation of c-Myc is mediated through PKC, the c-Src family of tyrosine kinases, and the MAP kinase pathway. It could be possible that the eect of these kinases on the expression of c-Myc is linked to their role in the organization of the cytoskeleton. However, speci®c inhibition of phosphatidylinositol 3-kinase, whose activity is also regulated by cell adhesion and which has been implicated in cell migration, does not alter the induction of c-Myc (data not shown). Furthermore, treatment of A1N4 with TPA, which does not reduce cell adhesion and spreading on ®bronectin, still blocks the induction of c-Myc. Together, these observations suggest that PKC, Src and MAPK are involved in a direct adhesiondependent signaling pathway inducing the expression of c-Myc.
Previous studies have indicated that c-Src is involved in the transcriptional regulation of c-myc in response to growth factors (Barone and Courtneidge, 1995) . In addition, it has been suggested that the Ras/Raf/MEK/ MAPK pathway may play a role in the regulation of AP-1 expression and function, whereas c-Src regulates the expression of c-Myc (Barone and Courtneidge, 1995; Roussel et al., 1991) . However, other studies have suggested a connection between this MAP kinase pathway and the expression of c-Myc. Transfections of murine ®broblasts with conditionally active c-Raf and H-Ras result in an increase in c-Myc mRNA (Lloyd et al., 1989; Kerkho et al., 1998) . Ki-Ras has also been implicated in the regulation of c-Myc in colon cancer cells (Shirasawa et al., 1993) . In addition, the Ras/Raf/ MEK pathway mediates the induction of c-Myc by CSF-1 and v-Alb (Weber et al., 1997; Cheng et al., 1999) . In fact, both the Raf/MEK/MAPK pathway and v-Src have been shown to complement a defective mutant colony-stimulating factor-1 receptor in NIH3T3. Furthermore, in that model v-Src requires the activation of MEK to induce the expression of cMyc (Aziz et al., 1999) . It has also been suggested that c-Src is an upstream activator of the MAP kinases in the integrin signal transduction pathways. Multiple, non-linear pathways are believed to link integrininduced activation of c-Src and the activation of the MAPK pathway. Through its association and phosphorylation of FAK, c-Src creates a binding site for the Grb2 adaptor protein (Schlaepfer et al., 1998; . Furthermore, c-Src induces Shc phosphorylation, and the c-Src substrate p130Cas enhances Grb2 association with Shc. This event has been shown to mediate c-Src-induced activation of serum response elements through the Ras/MEK/ERK pathway (Hakak and Martin, 1999; Schlaepfer et al., 1998) .
Our results reported here, together with the experiments described above, suggest the following model (Figure 8 ). Cell adhesion to ®bronectin through b1 integrin results in the activation of c-Src. c-Src, through FAK/p130CAS/Shc/Grb2 adaptor proteins, participates in the activation of the Ras/Raf/MEK/ ERK signaling cascade, which in turn induces the expression of c-Myc. Our results do not exclude the possibility that c-Src can also induce c-Myc, independent of the MAP kinase pathway. Indeed, several signals are believed to cooperate with the MEK/MAP kinase pathway, in response to CSF-1, to induce the expression of c-Myc (Cheng et al., 1999) . c-Src can possibly regulate the expression of c-myc, independent of the MAPK pathway, through the activation of the STAT family of transcription factors, since c-Src can activate STAT-3 independent of ERK activation, and since STAT 3 has been suggested to drive the transcription of c-myc (Goi et al., 2000; Kiuchi et al., 1999) . We also provide evidence, using PKC inhibitors, that PKC is implicated in the adhesion-dependent regulation of c-Myc. PKC is activated following cell adhesion to ®bronectin, and can modulate the integrininduced activation of c-Src and of the Ras/Raf/MEK/ ERK pathway (Vuori and Ruoslahti, 1993; Schlaepfer et al., 1998; Miranti et al., 1999; Howe and Juliano, 1998) . Further experiments will be required to determine whether collagen-induced expression of cMyc involves a parallel signaling pathway.
The molecular mechanisms by which c-Src and the MAP kinase pathway regulate the expression of c-Myc are not yet fully characterized, and their understanding requires further studies. Both c-Src and MAPK have been shown to regulate the levels of c-Myc mRNA suggesting transcriptional regulation. Elements in the cmyc promoter that confer adhesion-responsiveness to the c-myc gene still need to be de®ned. Two transcription factors might participate in the cell adhesion-dependent regulation of the transcription of c-Myc. First, the ERK1/2 phosphorylates and activates the Ets family of transcription factors. Ets-1 has been shown to induce the expression of reporter genes, under the control of the c-myc promoter, through the binding of the E2F site in the promoter of c-myc (Roussel et al., 1994) . In addition, c-Src, independent of the MAP kinase pathway, might regulate the transcription of the c-myc gene through the activation of the STAT3 transcription factor (Kiuchi et al., 1999) . Alternatively, the MAPK pathway has been shown to increase the phosphorylation of histone H3. This histone phosphorylation has been associated with increased transcription of the early genes, including cmyc (Chadee et al., 1999) .
An additional, post-transcriptional regulation of cMyc by cell adhesion should not be excluded. It is tempting to speculate that cell adhesion may alter the stability of c-Myc, since c-Ras has been shown to stabilize c-Myc (Sears et al., 1999) , and since we have shown that the MAP kinase pathway regulates the levels of c-Myc protein in response to ®bronectin.
Materials and methods
Reagents and antibodies
184A1N4 (referred to hereafter as A1N4) is a non-tumorgenic cell line derived from a primary culture of human mammary epithelial cells that were immortalized with benzo(a)pyrene (provided by Dr MR Stampfer, University of California, Berkeley CA, USA) (Stampfer and Bartley, 1985) . For c-Myc Western blotting, antibody from the c-Myc 1-9E10.2 hybridoma (ATCC, Rockville, MD, USA) (Evan et al., 1985) was used. Blocking antibody against human b1 integrin (M13) was purchased from Bohringer Mannhein (Indianapolis, IN, USA). Total Erk1/2 MAP kinase was detected with the anti-MAPK1-2 polyclonal antibody from Upstate Biotechnology (Lake Placid, NY, USA), and the phosphorylated form was detected with the monoclonal antibody E10 against phospho Erk1/2 (New England Biolab, Beverly, MA, USA). The anti-phospho-tyrosine antibody RC20:HRPO was from Transduction Laboratory (San Diego, CA, USA), anti-FAK[pY861] from Biosource International (Camarillo, CA, USA), and anti-tubulin alpha Ab2 from Neomarker (Fremont, CA, USA). The pharmacologic inhibitors Cycloheximide, Herbimycin A and Phorbol 12-Myristate 13-Acetate, were purchased from Sigma (St Louis, MO, USA), PP1 and PD98059, H89 and Staurosporine from Biomol (Plymouth Meeting, PA, USA), and Calphostin C was purchased from Alexis Corporation (Pittsburgh, PA, USA).
Cell culture and cell adhesion to ECM A1N4 cells were trypsinized and plated at low density (6.6610 3 cells/cm 2 ). They were allowed to regenerate their cell suface integrins and to adhere to tissue culture dishes in complete medium, IMEM (Gibco ± BRL, Rockville, MD, USA), supplemented with 0.5% fetal bovine serum (Gibco ± BRL), 0.5 mg/ml hydrocortisone (Sigma, St Louis, MO, USA), 5 mg/ml insulin (Bio¯uids, Rockville, MD, USA) and 10 ng/ml epidermal growth factor (EGF) (Collaborative Biomedical Research, Waltham, MA, USA) for 5 ± 7 h. Cells were then washed twice with phosphate buered saline (PBS), and maintained in a low serum, EGF-free medium (IMEM from Gibco ± BRL, supplemented with 0.5% fetal bovine serum (Gibco ± BRL), 0.5 mg/ml hydrocortisone (Sigma), 5 mg/ml insulin (Bio¯uids) for 48 ± 72 h to synchronize the cells in G0/G1 (Stampfer et al., 1993) .
Quiescent cells were then detached with 10 mM EDTA in PBS, washed in synchronization medium and unless speci®ed otherwise in the ®gure legends, they were resuspended in synchronization medium without EGF and transferred to ECM-coated petri dishes or to ®bronectin-suspension culture.
ECM-coated plates were prepared by coating 60 mm bacterial petri dishes with either 1 mg/cm 2 of human ®bronectin diluted in PBS, 1 mg/cm 2 collagen type IV diluted in 0.05 N HCl, or 5 mg/cm 2 collagen type I diluted in 0.02 N acetic acid (Collaborative Biomedical Research, Becton Dickinson, Franklin Lakes, NJ, USA) for 1 h at room temperature. The plates were then blocked for 30 min ± 1 h with 1% BSA and washed three times with PBS.
For the stimulation of cells in suspension with ®bronectin, quiescent cells were resuspended in 2 ml of synchronization medium, containing either 5 ± 10 mg/ml of ®bronectin or microbeads coated with either ®bronectin or BSA (®ve beads/cells), and maintained in suspension rotating at 378C for 1 h. Fibronectin-coated magnetic beads were prepared as described by Plopper and Ingber (1993) . 3610 6 tosylactivated, 4.5 mm diameter microbeads (Dynal, Lake Success, NY, USA) were coated with 8 mg of ®bronectin or 1% BSA (Fraction V, Sigma) in carbonate buer pH 9.4 at 378C overnight. Beads were washed and free tosyl groups were blocked for 4 h by rotating at 378C with 0.2 M Tris pH 8.0. Beads were then blocked in synchronization medium containing 1% BSA for 30 min and washed twice with medium before being added to the suspension of cells.
Cell lysis and immunoblotting
For preparations of whole cell extracts, adherent cells were scraped in PBS, and non-adherent cells collected and pelleted by centrifugation (15006g). The cell pellets were lysed on ice in lysis buer (1% TritonX-100, 50 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, 50 mM sodium¯uoride, 0.5 mM sodium orthovanadate, 60 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mg/ ml pepstatin, 10 mg/ml PMSF). Cellular debris was centrifuged for 10 min at 14 000 g. Equal amounts of proteins, as determined by the BCA protein micro assay (Pierce, Rockford, IL, USA), were resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS ± PAGE), and electroblotted onto PVDF membranes (Millipore, Bedford, MA, USA). For immunoblotting, membranes were blocked in PBS-0.1% Tween 20 with 5% milk overnight at 48C. The blots were then incubated with the primary antibody for 1 h at room temperature, followed by a 1 h incubation with either a 1 : 10 000 dilution goat anti-mouse secondary antibody conjugated with horseradish peroxidase (Biorad, Hercules, CA, USA), or a 1 : 5000 dilution of anti-rabbit HRP-linked secondary antibody (Amersham, Arlington Heights, IL, USA). Immunoreactive proteins were detected with chemiluminescent substrate (Pierce, Rockford, IL, USA). Equal protein loading was con®rmed by amino black staining of the membrane.
Northern blotting
To prepare total cellular RNA, cells were collected and resuspended in 1 ml of Rnazol (Tel-test, Inc., Friendswood, TX, USA). The RNA was prepared according to the manufacturer instructions. Ten mg of total RNA was separated on 1% agarose-formaldehyde gels and transferred onto N-Hybond nylon membranes (Amersham). Blots were cross linked by UV light exposure (UV stratalinker, Stratagene, La Jolla, CA, USA) and prehybridized in 50% formaldehyde, 56SSPE, 56Denhardt, 0.5% SDS and 0.2 mg/ml heat denatured salmon sperm DNA at 428C for 2 h. c-Myc mRNA expression were detected using randomly primed radiolabeled probes (Pharmacia, Piscataway, NJ, USA) generated from c-Myc cDNA (Watt et al., 1983) . Probes were heat denatured, added to the pre-hybridization solution, and hybridized overnight at 428C. Blots were reprobed for GAPDH as loading control.
c-Src in vitro kinase assay
Cells attached to ®bronectin were lysed in lysis buer containing 0.5% sodium deoxycholate and 0.1% SDS. c-Src was immunoprecipitated with anti-c-Src antibody (GD11)(Upstate Biotechnology). The immunoprecipitates were resuspended in kinase buer (20 mM HEPES, pH 7.0, 10 mM MnCl 2 , 10 mM sodium orthovanadate, 1 mM DTT) containing 2 mg of acid denatured rabbit muscle enolase as an in vitro substrate and 5 mCi [g 32 P]ATP (3000 Ci/mmole) (NEN, Boston, MA, USA). The samples were incubated at 308C for 10 min. The reaction was stopped by adding 26SDS sample buer, and the samples were boiled and resolved by SDS ± PAGE. The gel was stained with Coomassie Blue (BioRad) to verify equal loading of the substrate; the extent of phosphorylation was determined by autoradiography.
